Published in
Elsevier, International Journal of Infectious Diseases, (92), p. 71-77, 2020
DOI: 10.1016/j.ijid.2019.12.029
Links
Tools
Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
Journal article published in 2020 by
Po-Hsien Kuo 
,
Hsin-Yun Sun,
Yu-Chung Chuang ,
Pei-Ying Wu,
Wen-Chun Liu,
Chien-Ching Hung
,
Hsin-Yun Sun,
Yu-Chung Chuang ,
Pei-Ying Wu,
Wen-Chun Liu,
Chien-Ching Hung
This paper is made freely available by the publisher.
Full text: Download
Data provided by 